Exponent, inc. (EXPO)
CashFlow / Yearly
Jan'20Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09
Cash flows from operating activities:
Net income

82,460

72,254

41,305

47,480

43,599

40,701

38,640

37,225

32,695

27,521

22,127

Adjustments to reconcile net income to net cash used in operating activities:
Depreciation and amortization of property, equipment and leasehold improvements

6,806

6,292

6,285

6,131

5,479

5,404

4,951

4,711

4,411

4,323

4,352

Amortization of premiums and accretion of discounts on short-term investments

516

114

-

-2

-595

-885

-340

-560

-344

-35

-170

Deferred rent expense

-

-175

362

-340

-65

-273

800

-310

-417

454

-370

Provision for contract losses and doubtful accounts

2,224

1,848

2,506

2,452

929

1,718

1,705

1,763

1,987

1,809

3,918

Stock-based compensation

17,466

16,993

16,155

13,333

12,959

13,079

13,168

12,378

10,340

9,257

7,931

Deferred income tax provision

-2,845

-3,715

11,786

-2,602

-3,827

-6,077

-3,398

-4,194

-3,663

-3,229

-4,100

Excess tax benefit for equity incentive plans

-

-

-

-

6,396

5,100

4,267

3,948

2,378

3,972

3,282

Changes in operating assets and liabilities:
Accounts receivable

16,548

-2,438

25,197

1,284

3,138

11,106

-6,676

14,059

3,018

11,181

4,372

Prepaid expenses and other current assets

3,343

11,047

-2,867

598

-421

5,320

4,596

3,379

1,929

8,520

-635

Change in operating leases

-205

-

-

-

-

-

-

-

-

-

-

Accounts payable and accrued liabilities

6,715

-4,620

5,984

-370

7,718

6,142

3,002

7,374

-997

9,485

714

Accrued payroll and employee benefits

11,891

9,820

5,831

2,920

2,639

6,744

4,665

9,667

9,404

8,696

507

Deferred revenues

3,544

864

678

-178

-424

1,455

106

717

-183

1,374

-1,414

Net cash used in operating activities

108,059

91,188

67,838

66,946

60,489

48,252

61,792

48,505

46,596

36,052

26,816

Cash flows from investing activities:
Capital expenditures

23,038

16,298

4,725

14,393

5,379

4,947

6,226

4,942

3,835

2,475

2,017

Purchase of short-term investments

38,693

52,522

28,997

51,000

43,946

5,260

33,422

515

26,599

-

-

Maturity of short-term investments

66,000

43,000

16,000

37,950

22,290

11,642

19,190

3,770

0

7,405

18,153

Sale of short-term investments

-

-

-

-

-

1,000

1,578

518

1,080

-

-

Net cash provided by (used in) investing activities

4,269

-25,820

-17,722

-27,443

-27,035

2,435

-18,880

-1,169

-29,354

4,930

16,136

Cash flows from financing activities:
Excess tax benefit for equity incentive plans

-

-

-

-

6,396

5,100

4,267

3,948

2,378

3,972

3,282

Payroll taxes for restricted stock units

11,183

8,839

9,520

7,685

7,365

6,356

6,402

3,531

3,527

1,946

1,849

Repurchase of common stock

21,957

27,915

11,931

24,456

23,314

30,921

25,519

22,887

40,573

7,145

12,875

Exercise of stock-based payment awards

3,229

1,474

2,025

1,756

3,014

2,107

1,812

3,611

2,378

2,899

3,682

Dividends and dividend equivalents rights

33,503

27,220

21,835

18,781

15,647

13,058

7,927

0

0

-

-

Net cash used in financing activities

-63,414

-62,500

-41,261

-49,166

-36,916

-43,128

-33,769

-18,859

-39,344

-2,220

-7,760

Effect of foreign currency exchange rates on cash and cash equivalents

463

-603

972

-1,121

-277

-1,017

537

352

-8

-108

105

Net decrease in cash and cash equivalents

49,377

2,265

9,827

-10,784

-3,739

6,542

9,680

28,829

-22,110

38,654

35,297